Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 61-66 , January 2008

Preparation and first evaluation of [18F]FE@SUPPY: a new PET tracer for the adenosine A3 receptor

  • Wolfgang Wadsak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Inorganic Chemistry, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Leonhard-Key Mien

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Karem Shanab

      Affiliations

    • Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Dagmar E. Ettlinger

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Daniela Haeusler

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Karoline Sindelar

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Rupert R. Lanzenberger

      Affiliations

    • Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Helmut Spreitzer

      Affiliations

    • Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Helmut Viernstein

      Affiliations

    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Bernhard K. Keppler

      Affiliations

    • Department of Inorganic Chemistry, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Robert Dudczak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Kurt Kletter

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Markus Mitterhauser

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • Hospital Pharmacy of the General Hospital of Vienna, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, AKH Wien, Waehringer Guertel 18–20, A-1090 Vienna, Austria. Tel.: +43 1 40400 1557; fax: +43 1 40400 1559.

Received 13 August 2007 ,Revised 11 September 2007 ,Accepted 27 September 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(07)00243-0

doi: 10.1016/j.nucmedbio.2007.09.004

Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 61-66 , January 2008

Article Tools

* Image Usage & Resolution